<DOC>
	<DOCNO>NCT00564954</DOCNO>
	<brief_summary>This study compare efficacy dex-methylphenidate extend release 20 mg versus placebo 8-hour laboratory classroom day .</brief_summary>
	<brief_title>A Study Dex-methylphenidate Extended Release Children ( 6-12 Years ) With Attention-Deficit/Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Dexmethylphenidate Hydrochloride</mesh_term>
	<criteria>Male female subject age 612 year , inclusive . Subjects meet DSMIV criterion ADHD type , establish KSADSPL ( Kiddie Schedule Affective Disorders SchizophreniaPresent Lifetime Version ) . If DSMIVdefined ADHD diagnosis difficult establish due possible comorbidity , subject enrol study . Subjects stabilize total daily dose near equivalent 4060 mg methylphenidate 2030 mg dmethylphenidate least two week prior screen visit ( ConcertaÂ® 36 mg 54 mg allowable ) Parent guardian unable unwilling complete Conner 's ADHD/DSMIV Scale Parents ( CADSP ) Daily Diary Card Diagnosed tic disorder Tourette 's syndrome History seizure disorder The presence know medical condition would preclude use methylphenidate . A history ( within past year ) presence clinically significant cardiovascular , cerebrovascular , renal , hepatic , gastrointestinal , pulmonary , immunological , hematological , endocrine , neurological disease ALT , AST , GGPT serum creatinine great 2X ULN Screening A history psychiatric illness substance use disorder ( e.g. , schizophrenia , bipolar disorder , autism , abuse dependence , depression , severe Conduct Disorder severe Oppositional defiant disorder ) Subjects participated investigational trial within past 4 week ( 28 day ) exclude Subjects currently take antidepressant psychotropic medication Subjects initiate psychotherapy three month prior randomization Subjects positive urine drug screen Subjects history poor response intolerance methylphenidate dmethylphenidate Other protocol define inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>ADHD</keyword>
	<keyword>child</keyword>
	<keyword>laboratory classroom</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
</DOC>